Yang Zhao, Ping Yu-Qi, Wang Ming-Wei, Zhang Chao, Zhou Shu-Hua, Xi Yue-Tong, Zhu Kong-Kai, Ding Wei, Zhang Qi-Yue, Song Zhi-Chen, Zhao Ru-Jia, He Zi-Lu, Wang Meng-Xin, Qi Lei, Ullmann Christian, Ricken Albert, Schöneberg Torsten, Gan Zhen-Ji, Yu Xiao, Xiao Peng, Yi Fan, Liebscher Ines, Sun Jin-Peng
Key Laboratory Experimental Teratology of the Ministry of Education, New Cornerstone Science Laboratory, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, and Advanced Medical Research Institute, NHC Key Laboratory of Otorhinolaryngology, Qilu hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.
Cell. 2025 Mar 20;188(6):1589-1604.e24. doi: 10.1016/j.cell.2025.01.006. Epub 2025 Jan 29.
Androgens, such as 5α-dihydrotestosterone (5α-DHT), regulate numerous functions by binding to nuclear androgen receptors (ARs) and potential unknown membrane receptors. Here, we report that the androgen 5α-DHT activates membrane receptor GPR133 in muscle cells, thereby increasing intracellular cyclic AMP (cAMP) levels and enhancing muscle strength. Further cryoelectron microscopy (cryo-EM) structural analysis of GPR133-Gs in complex with 5α-DHT or its derivative methenolone (MET) reveals the structural basis for androgen recognition. Notably, the presence of the "Φ(F/L)-F-W" and the "F××N/D" motifs, which recognize the hydrophobic steroid core and polar groups, respectively, are common in adhesion GPCRs (aGPCRs), suggesting that many aGPCRs may recognize different steroid hormones. Finally, we exploited in silico screening methods to identify a small molecule, AP503, which activates GPR133 and separates the beneficial muscle-strengthening effects from side effects mediated by AR. Thus, GPR133 represents an androgen membrane receptor that contributes to normal androgen physiology and has important therapeutic potentials.
雄激素,如5α-二氢睾酮(5α-DHT),通过与核雄激素受体(ARs)和潜在的未知膜受体结合来调节多种功能。在此,我们报告雄激素5α-DHT可激活肌肉细胞中的膜受体GPR133,从而提高细胞内环磷酸腺苷(cAMP)水平并增强肌肉力量。进一步对与5α-DHT或其衍生物美替诺龙(MET)结合的GPR133-Gs进行冷冻电子显微镜(cryo-EM)结构分析,揭示了雄激素识别的结构基础。值得注意的是,分别识别疏水性甾体核心和亲水基团的“Φ(F/L)-F-W”和“F××N/D”基序在粘附G蛋白偶联受体(aGPCRs)中很常见,这表明许多aGPCRs可能识别不同的甾体激素。最后,我们利用计算机筛选方法鉴定出一种小分子AP503,它可激活GPR133,并将有益的肌肉增强作用与AR介导的副作用区分开来。因此,GPR133代表一种雄激素膜受体,它有助于正常的雄激素生理功能,并具有重要的治疗潜力。